Immunomedics Message Board


What's the Strategy in the U.S. for Neovasc's Reducer?

7 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

BLA Resubmission for sacituzumab govitecan

10 months ago

Ended up 5% down the following day. Hate getting caught in these biotech offerings. They always happen.

What's the Strategy in the U.S. for Neovasc's Reducer?

7 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Loading...